Affordable Access

Publisher Website

Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses.

Authors
Type
Published Article
Journal
Journal of Viral Hepatitis
1365-2893
Publisher
Wiley Blackwell (Blackwell Publishing)
Publication Date
Volume
17
Issue
5
Pages
336–344
Identifiers
DOI: 10.1111/j.1365-2893.2009.01182.x
PMID: 19678893
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments